Search Results

Job Trends

GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector

GenScript Biotech, a global leader in life science research and manufacturing services, along with its subsidiaries GenScript ProBio and Legend Biotech, will be attending the 42nd JPM Healthcare Conference held in San Francisco, California, USA, from January 8 to 11, 2024.

January 4, 2024

·

3 min read

Press Releases

ProBio Announces Six Presentations at American Society of Gene and Cell Therapy 28th Annual Meeting 2025

April 23, 2025

·

4 min read

Business

GenScript ProBio Partners With NuclixBio to Pave the Way for South Korea’s First Large-scale Production Process for “Circular RNA Therapeutics”

GenScript ProBio and NuclixBio announced on 9th Nov that they have entered into a strategic business agreement to develop the first circular RNA-based anticancer drug in South Korea.

November 9, 2023

·

2 min read

Business

GenScript ProBio Signs Viral Vector Manufacturing MOU With Curocell for Next-Generation CAR-T Therapy

On November 10, a global multimodality CDMO, GenScript ProBio and specialized CAR-T therapy firm Curocell signed a strategic partnership MOU for the production of viral vectors necessary for the development of next generation of CAR-T therapy, marking another significant step in their ongoing collaboration.

November 10, 2023

·

3 min read

Business

A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)

In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.

January 10, 2025

·

1 min read

·

Lori Ellis

Press Releases

ProBio to Present Data on Its CD3 Agonistic Single Domain Antibody Platform for Accelerated Development of T Cell Engager Multi-Specific Antibodies

April 14, 2025

·

3 min read

GenScript ProBio and Comprehensive Cell Solutions Form a Pioneering Partnership to Expedite Cell and Gene Therapy Development and Manufacturing

GenScript ProBio, a global contract development and manufacturing organization, and Comprehensive Cell Solutions (CCS), a leader in cell therapy development and manufacturing, have partnered to spearhead

June 8, 2023

·

4 min read

Press Releases

ProBio Announces New Executive Appointments

December 6, 2024

·

4 min read

Pharm Country

GenScript ProBio and Comprehensive Cell Solutions, a Business Unit of the New York Blood Center Enterprises, Form a Pioneering Partnership to Expedite Cell and Gene Therapy Development and Manufacturing

GenScript ProBio and Comprehensive Cell Solutions have partnered to spearhead the development of cell and gene therapies, offering a unique and seamlessly integrated solution that spans cell collections and apheresis through cryopreservation of final therapeutics.

June 7, 2023

·

4 min read

Genetically engineered chimeric antigen receptor immune cell with implanted mrna gene strand - 3d illustration

In partnership with GenScript

Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies

At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ongoing challenges in manufacturing, distribution, treatment center capacity, and global payment structures for cell and gene therapies.

April 14, 2025

·

6 min read

·

BioSpace Insights